AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Bronchitis Treatment Market Analysis & Trends During the Forecast Period 2018-2026 - ResearchAndMarkets.com

January 2, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 2, 2020--

The “Bronchitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026” report has been added to ResearchAndMarkets.com’s offering.

Global Bronchitis Treatment market: Overview

This report analyzes the current and future scenario of the global bronchitis treatment market. Rise in geriatric population, high incidence of bronchitis, and increase in cigarette smoking patient pool are major drivers of the global market.

The global bronchitis treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on type, drug class, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global bronchitis treatment market.

Global Bronchitis Treatment Market: Key Segments

The global bronchitis treatment market has been segmented based on type, drug class, distribution channel, and region. Furthermore, in terms of type, the market has been divided into chronic bronchitis and acute bronchitis. The chronic bronchitis segment is likely to account for a leading share of the global market during the forecast period owing to high morbidity and mortality rate. Based on drug class, the bronchitis treatment market has been classified into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment held a significant share of the market in 2017 due to a rise in the sale of over-the-counter bronchitis therapeutics. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Key Topics Covered:

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

3.1. Global Bronchitis Treatment Market: Market Snapshot

4. Market Overview

4.1. Global Bronchitis Treatment Market: Type Overview

4.2. Global Bronchitis Treatment Market: Key Industry Developments

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Bronchitis Treatment Market Revenue Projections, 2016-2026

4.5. Porter’s Five Forces Analysis

4.6. Global Bronchitis Treatment Market Outlook

5. Market Outlook

5.1. Pipeline Analysis

5.2. Key Market Trends

5.3. Disease Epidemiology

6. Global Bronchitis Treatment Market Analysis, by Type

6.1. Key Findings

6.2. Introduction

6.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Type

6.4. Global Bronchitis Treatment Market Value Forecast, by Type

6.5. Global Bronchitis Treatment Market Analysis, by Type

7. Global Bronchitis Treatment Market Analysis and Forecast, by Drug Class

7.1. Key Findings

7.2. Introduction

7.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Drug Class

7.4. Global Bronchitis Treatment Market Value Forecast, by Drug Class

7.5. Global Bronchitis Treatment Market Analysis, by Drug Class

8. Global Bronchitis Treatment Market Analysis, by Distribution Channel

8.1. Key Findings

8.2. Introduction

8.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

8.4. Global Bronchitis Treatment Market Value Forecast, by Distribution Channel

8.5. Global Bronchitis Treatment Market Analysis, by Distribution Channel

9. Global Bronchitis Treatment Market Analysis, by Region

9.1. Global Bronchitis Treatment Market Scenario, by Country

9.2. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Region

9.3. Global Bronchitis Treatment Market Value Forecast, by Region

10. North America Bronchitis Treatment Market Analysis

10.1. Key Findings

10.2. North America Bronchitis Treatment Market Overview

10.3. North America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country

10.4. North America Bronchitis Treatment Market Forecast, by Country

10.5. North America Bronchitis Treatment Market Value Share Analysis, by Type

10.6. North America Bronchitis Treatment Market Forecast, by Type

10.7. North America Bronchitis Treatment Market Value Share Analysis, by Drug Class

10.8. North America Bronchitis Treatment Market Forecast, by Drug Class

10.9. North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel

10.10. North America Bronchitis Treatment Market Forecast, by Distribution Channel

10.11. North America Bronchitis Treatment Market Attractiveness Analysis

11. Europe Bronchitis Treatment Market Analysis

12. Asia Pacific Bronchitis Treatment Market Analysis

13. Latin America Bronchitis Treatment Market Analysis

14. Middle East & Africa Bronchitis Treatment Market Analysis

15. Competition Landscape

15.1. Bronchitis Treatment Market Share Analysis, by Company, 2017

15.2. Competition Matrix

15.3. Company Profiles

15.3.1. AstraZeneca

15.3.2. Boehringer Ingelheim International GmbH

15.3.3. GlaxoSmithKline plc

15.3.4. Novartis AG

15.3.5. Melinta Therapeutics

15.3.6. Dr Reddy’s Laboratories Ltd

15.3.7. Sanofi S.A.

For more information about this report visit https://www.researchandmarkets.com/r/74uq2s

View source version on businesswire.com:https://www.businesswire.com/news/home/20200102005205/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/02/2020 05:39 AM/DISC: 01/02/2020 05:39 AM

http://www.businesswire.com/news/home/20200102005205/en